MedeA Project

Development of a system of medicine and personalized prescription validated in real clinical conditions in the Spanish Extremadura Health Service, connectable to his electronic prescription system.

It comprises the following components:

(a) the personalized prescription system itself
(b) development of a pharmacogenetic analysis system
(c) evaluation system of patients and volunteers for clinical trials
(d) system for evaluating adverse reactions to drugs.

Global contract value: 2,192K euros
Contracting decision: February 2022
Ending: February 2023

This content is restricted to Investors. If you are an existing investor, please log in.

Become an investor!.

 Other research projects

COVID-19 project

COVID-19 project

We are conducting a hospital clinical trial to measure the infectivity of the SARS-CoV-2 virus and slow down the replication of the virus in host cells.